| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.0M | -1.0% |
| Cost of Revenue | $2.9M | -11.6% |
| Gross Profit | $8.2M | +3.4% |
| R&D Expense | $771K | +216.8% |
| SG&A Expense | $6.6M | +6.1% |
| Operating Income | $1.6M | -6.6% |
| Pre-tax Income | $2.1M | -1.0% |
| Income Tax | $462K | -13.2% |
| Net Income | $1.6M | +3.2% |
| EPS (Basic) | $0.35 | +2.9% |
| EPS (Diluted) | $0.35 | +2.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.2M | +264.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $2.8M | +17.9% |
| Inventory | $1.6M | -16.5% |
| Current Assets | $13.3M | +12.3% |
| Total Assets | $14.4M | +6.3% |
| Current Liabilities | $493K | -57.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.8M | -10.5% |
| Capital Expenditures | $31K | -75.9% |
| Investing Cash Flow | $4.5M | +245.8% |
| Financing Cash Flow | -$363K | -161.3% |
| Free Cash Flow | $1.8M | -6.0% |
| $1.5M |
| -26.1% |
| Stockholders' Equity | $12.8M | +12.1% |